ABT Financial Facts

Total Operating Cost and Expenses: 4.41B
Net foreign exchange loss (gain): 9M
See Full Income Statement

Total Assets: 39.5B
Finished products: 1.76B
See Full Balance Sheet

Abbott Labs (ABT) Earnings

  |   Expand Research on ABT
Next EPS Date 7/21/21 *Est. EPS Growth Rate +131.6% *Last Qtr.
Average EPS % Beat Rate +14.8% Revenue Growth Rate +43.8% *Last Qtr.
Average % Move 1-Wk after EPS +1.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/20/21 Q221 $1.32$1.27 +$0.05$10.5B$10.69B = Details
1/27/21 Q121 $1.45$1.35 +$0.10$10.7B$9.94B = Details
8/10/20 Q420 N/A$0.89 N/A N/A$8.48B N/A N/A
10/21/20 Q320 $0.98$0.90 +$0.08$8B$8.51B Details
7/16/20 Q220 $0.57$0.41 +$0.16$7.3B$6.75B Details
4/16/20 Q120 $0.65$0.58 +$0.07$7.7B$7.34B Details
1/22/20 Q419 $0.95$0.95 $0.00$8.3B$8.26B Details
10/16/19 Q319 $0.84$0.84 $0.00$8.1B$8.11B = Details